Genetic Association of CDC2 with Cerebrospinal Fluid Tau in Alzheimer’s Disease
暂无分享,去创建一个
K. Blennow | H. Hampel | L. Wahlund | L. Minthon | J. Prince | H. Zetterberg | K. Buerger | A. Johansson | Annica Johansson
[1] Tin Tin Su,et al. Cell Cycle Regulation , 2007, Fly.
[2] K. Blennow,et al. Increased frequency of a new polymorphism in the cell division cycle 2 (cdc2) gene in patients with Alzheimer's disease and frontotemporal dementia , 2003, Neuroscience Letters.
[3] Esther B. E. Becker,et al. JNK Phosphorylation and Activation of BAD Couples the Stress-activated Signaling Pathway to the Cell Death Machinery* , 2002, The Journal of Biological Chemistry.
[4] H. Braak,et al. Up-regulation of cell division cycle (cdc) 2 kinase in neurons with early stage Alzheimer's disease neurofibrillary degeneration , 2002, Acta Neuropathologica.
[5] Maria K. Lehtinen,et al. Cdc2 phosphorylation of BAD links the cell cycle to the cell death machinery. , 2002, Molecular cell.
[6] Marc W. Kirschner,et al. Timing of Events in Mitosis , 2002, Current Biology.
[7] R. Bowser,et al. Altered subcellular distribution of transcriptional regulators in response to Aβ peptide and during Alzheimer's disease , 2001, Mechanisms of Ageing and Development.
[8] J. Enghild,et al. Cdc2 phosphorylation of nucleolin demarcates mitotic stages and Alzheimer’s disease pathology , 2001, Neurobiology of Aging.
[9] K. Blennow,et al. Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice. , 2001, Archives of neurology.
[10] J. Blangero,et al. Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. , 2000, Science.
[11] M. Owen,et al. Susceptibility locus for Alzheimer's disease on chromosome 10. , 2000, Science.
[12] M G McInnis,et al. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. , 2000, Science.
[13] G. Johnson,et al. Tau Protein Is Hyperphosphorylated in a Site‐Specific Manner in Apoptotic Neuronal PC12 Cells , 2000, Journal of neurochemistry.
[14] I. Vincent,et al. Mitotic activation: a convergent mechanism for a cohort of neurodegenerative diseases , 2000, Neurobiology of Aging.
[15] K. Blennow,et al. Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization , 2000, Neuroscience Letters.
[16] K. Blennow,et al. Standardization of measurement of β-amyloid(1-42) in cerebrospinal fluid and plasma , 2000, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[17] David S. Park,et al. Involvement of Cell Cycle Elements, Cyclin-dependent Kinases, pRb, and E2F·DP, in B-amyloid-induced Neuronal Death* , 1999, The Journal of Biological Chemistry.
[18] K. Blennow,et al. Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease. , 1999, Archives of neurology.
[19] G. Evan,et al. A matter of life and cell death. , 1998, Science.
[20] J. Meyer,et al. Multiple threshold model for the onset of Alzheimer's disease in the NAS-NRC twin panel. , 1998, American journal of medical genetics.
[21] Y. Kitamura,et al. Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease , 1998, Brain Research.
[22] J. Haines,et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.
[23] A. Smith,et al. Cell cycle markers in the hippocampus in Alzheimer’s disease , 1997, Acta Neuropathologica.
[24] G. Jicha,et al. Aberrant Expression of Mitotic Cdc2/Cyclin B1 Kinase in Degenerating Neurons of Alzheimer’s Disease Brain , 1997, The Journal of Neuroscience.
[25] A. Hyman,et al. Morphogenetic Properties of Microtubules and Mitotic Spindle Assembly , 1996, Cell.
[26] K. Blennow,et al. Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease? , 1995, Molecular and chemical neuropathology.
[27] X. Graña,et al. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). , 1995, Oncogene.
[28] P. Greengard,et al. Cell cycle‐dependent regulation of the phosphorylation and metabolism of the Alzheimer amyloid precursor protein. , 1994, The EMBO journal.
[29] K. Imahori,et al. A cdc2‐related kinase PSSALRE/cdk5 is homologous with the 30 kDa subunit of tau protein kinase II, a proline‐directed protein kinase associated with microtubule , 1993, FEBS letters.
[30] M. Pericak-Vance,et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[31] R. Braun,et al. Proline-directed phosphorylation of human Tau protein. , 1992, The Journal of biological chemistry.
[32] H. Feilotter,et al. Regulation of the G2-mitosis transition. , 1992, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[33] J. Ávila,et al. Implication of brain cdc2 and MAP2 kinases in the phosphorylation of tau protein in Alzheimer's disease , 1992, FEBS letters.
[34] N. Thomas,et al. Cell cycle regulation. , 1991, Blood reviews.
[35] S. M. Sumi,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.
[36] Douglas G. Altman,et al. Practical statistics for medical research , 1990 .
[37] R. Nussbaum,et al. Report of the committee on the genetic constitution of the X chromosome. , 1988, Cytogenetics and cell genetics.
[38] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[39] G. Lindwall,et al. Phosphorylation affects the ability of tau protein to promote microtubule assembly. , 1984, The Journal of biological chemistry.
[40] S. Folstein,et al. “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .
[41] B. Winblad,et al. Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis , 2004, Acta Neuropathologica.
[42] H. Braak,et al. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads , 2004, Acta Neuropathologica.
[43] J. Trojanowski,et al. Neurodegenerative tauopathies. , 2001, Annual review of neuroscience.
[44] J. Hardy,et al. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. , 1991, Trends in pharmacological sciences.
[45] H. Cann,et al. Report of the committee on the genetic constitution of chromosome 10. , 1990, Cytogenetics and cell genetics.